flytrader1 Posted - 9 hours ago

$CERE No news for months except for the FCC scare recently. They will release earnings shortly which most likely explains the rebound in price as the market anticipates that the deal will close in weeks.

paiocje Posted - 1 week ago

$CERE Why is pre-market on YF and stocktwits showing $44 but IBKR says no change from close?

paiocje Posted - 1 week ago

$CERE Is anyone actually active on this board? Remarkably quiet vs deals like SGEN

gentleowl Posted - 1 week ago

$CERE tomorrow 43$

TickerDD_com Posted - 3 weeks ago

From 6/17/2024, looking back across 21 Month-Ends for CERE, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $CERE #CERE #CEREStock #TickerDD #CEREPrice https://www.youtube.com/watch?v=VerL56oiKjI

PeedyWeedy Posted - 06/29/24

$CERE Is there an upcoming data release for darigabat, if so, when it is expected? Thanks.

KCSVEN Posted - 1 month ago

$CERE According to a Seeking Alpha article: "While there was no specific reason for the drop on Tuesday, some traders told Seeking Alpha there was some vague speculation out of unidentified broker that the FTC was gearing up for a lawsuit and that Cerevel (CERE) was increasingly looking like it may be the target for the regulator. Some people also attributed the weakness to the Russell index reconstitution on Friday and some options trades on Tuesday."

OpenOutcrier Posted - 1 month ago

RECAP 6/25 Unusual Puts: $CERE Aug 40/35 P Spd $LW Aug 75 P Live Breaking trading news www.openoutcrier.com

KCSVEN Posted - 1 month ago

$CERE FROM YAHOO BOARD Abbvie had their Parkinson’s drug turned down by the FDA today because they did not like what they found at the manufacturing plant run by a third-party unrelated company. The FDA said there are no issues at all with the actual drug and they are not making any requests for new studies or information about the drug, but yes, it could delay drug approval. people are probably worried that it will delay CERE’s drug as well, and if this would be considered a MAC that would allow abbvie to cancel the deal. Read the Delaware contract and you will see that that is not a MAC, even if they wanted out of the deal, and they do not. The contract specifies that drug approval is NOT a MAC, thus abbvie assumes all risk. This is simply people getting afraid, but they will quickly realize there’s no reason. Take advantage of it and buy some now. Even if the actual manufacturing and drug approval is delayed it has nothing to do with the timing of the buyout being finalized.

TeresaTrades Posted - 1 month ago

Heavy options volume $PTEN $ITB $BMBL $CERE $FYBR

flytrader1 Posted - 1 month ago

$CERE lots of bearish option action & implied volatility has jumped

KCSVEN Posted - 1 month ago

$CERE Not good this close to when a close should be happening to be down 5% on heavy volume with a Bearish Put Spread put on right before the move. "Could" be a bear raid but also could be a sign some negative news is coming, best to be on sidelines and see what happens.

DiamondHandsBTW Posted - 1 month ago

$CERE quick question what will happen to my live options if the merger gets passed through? Let's say I buy options that expire later in the year.

SouthHaus Posted - 1 month ago

$CERE Not an owner…yet. Not a FUDster. I am trying to figure out what could go wrong with this buyout. Both the (hopeful) acquirer’s board and the (proposed) acquired’s boards have signed off on the deal. I know there is a suit or multiple suite claiming the buyout price significantly undervalues CERE. But, really, on what bases might those suits go anywhere? Could the FTC oppose the deal on competition-stifling grounds? These kinds of deals go unopposed by the Feds all the time! At its current asking price, after satisfying my short term capital gains tax burdens, I am sitting here looking at an 8% gain per dollar invested…likely to be realized within the next 115 days. Opinions on the above are encouraged. Thanks in advance.

flytrader1 Posted - 1 month ago

$CERE bearish option action today. Can't find any news, wonder if something has leaked!

retireddprof Posted - 05/30/24

$CERE Anyone else think by now CERE is legally obligated to provide an update at to the merger status.

Stock_Titan Posted - 2 months ago

$CERE Cerevel’s Merger with AbbVie for $45 Per Share Leads to Investigation - Contact BFA Law to Discuss How this Impacts You https://www.stocktitan.net/news/CERE/cerevel-s-merger-with-abb-vie-for-45-per-share-leads-to-4ml7awl75yah.html

Stock_Titan Posted - 2 months ago

$CERE Is Cerevel’s Merger with AbbVie for $45 Per Share Too Low? BFA Law is Investigating https://www.stocktitan.net/news/CERE/is-cerevel-s-merger-with-abb-vie-for-45-per-share-too-low-bfa-law-is-gq2l27ydfshk.html

BioBioBio1 Posted - 2 months ago

$CERE will this ever close?

Stock_Titan Posted - 2 months ago

$CERE ACQUISITION ALERT BFA LLP Notifies Cerevel Therapeutics Shareholders of an Investigation into the Merger with AbbVie https://www.stocktitan.net/news/CERE/acquisition-alert-bfa-llp-notifies-cerevel-therapeutics-shareholders-ig6q1oemn7dt.html

DonCorleone77 Posted - 2 months ago

$CERE $OKTA $WRK $PCG $NVO Soros buys Okta, cuts Amazon in Q1 George Soros' Soros Fund Management disclosed in an SEC filing its holdings as of March 31, 2024. The fund's new buys during the first quarter included, by size of position, Cerevel Therapeutics (CERE), Okta (OKTA), WestRock (WRK), PG&E (PCG), and Sunrun (RUN). Soros exited five holdings during the quarter, including by size of previous position iShares Russell 2000 ETF (IWM), SPDR S&P 500 ETF Trust (SPY), SPDR Euro Stoxx 50 ETF (FEZ), Las Vegas Sands (LVS), and Birkenstock (BIRK). The fund increased its stake in multiple holdings, including by size of previous position Alphabet Class A (GOOGL), Aramark (ARMK), D.R. Horton (DHI), American Equity (AEL), and SPDR S&P Regional Banking ETF (KRE). Soros reduced its stake in multiple holdings, including by size of previous position Novo (NVO), Sempra (SRE), CRH (CRH), Amazon (AMZN), and AerCap (AER). The fund's top holdings as of March 31, in order of size, were Alphabet Class A, AerCap, American Equity, Novo, and Cerevel.

newsfile_corp Posted - 2 months ago

https://nfne.ws/209182 $CERE #Banking #FinancialServices #InvestmentBanking #Merger #NASDAQ #Investing

newsfile_corp Posted - 2 months ago

https://nfne.ws/209073 $CERE #Banking #FinancialServices #InvestmentBanking #NASDAQ #Investing

StockInvest_us Posted - 2 months ago

Signal alert: $CERE - Double Top https://stockinvest.us/l/HcjLzslxXL

fda_tracker Posted - 2 months ago

$CERE Phase 2 trial w/est May completion date NCT04244175: https://www.clinicaltrials.gov/study/NCT04244175 Trial Tracker: https://www.fdatracker.com/trial-tracker/

NakadasuTellaria Posted - 3 months ago

$RCI Barclays Trims Rogers Communications (NYSE:RCI) Target Price to $46.00 $CERE Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Receives $41.40 Average Target Price from Analysts $SPGI S&P Global Inc. (NYSE:SPGI) Receives $464.22 Average Target Price from Analysts $DCGO BTIG Research Trims DocGo (NASDAQ:DCGO) Target Price to $11.00 $WIMI Evaluate Research reiterated a "buy" rating with $7 latest price target for WIMI Hologram Cloud(NASDAQ: WIMI)

the_FDA Posted - 3 months ago

$CERE Great. Now filing as soon as possible so patients can get access to it as soon as possible.

luiselen Posted - 3 months ago

$SNOW Brokerages Set Snowflake Inc. (NYSE:SNOW) Target Price at $202.50 $RCI Barclays Trims Rogers Communications (NYSE:RCI) Target Price to $46.00 $CERE Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Receives $41.40 Average Target Price from Analysts $WIMI Evaluate Research reiterated a "buy" rating with $7 latest price target for WIMI Hologram Cloud(NASDAQ: WIMI)

ForestFoxes Posted - 3 months ago

I am even more excited about Annovis’ $ANVS P3 Early-Stage Parkinson’s disease study then their P2/3 Alzheimer’s study based on the size (523 n) and duration (7-8 months) with expected results this month. I’m super happy for those affected by Parkinson’s with Cerevel Therapeutics’ P3 study (507 n & 6.76 months) results today! https://investors.cerevel.com/news-releases/news-release-details/cerevel-therapeutics-announces-positive-topline-results-0 Amazing timing with AbbVie $ABBV being in the process of acquiring $CERE for $8.7B (which includes ALL of their pipeline) with the transaction expected to close by mid-2024. What a DEAL for ABBV 🙌 Hopefully, Annovis will also be acquired sometime this year 🤞 This is really great news for Parkinson’s patients with multiple companies (approx. 120+) working towards Rx's but with limited success until now 😊👍 P.S. Anavex $AVXL has a pending Alzheimer’s submission to the EMA and a Parkinson’s peer-review article pending.

biostock Posted - 3 months ago

$CERE A $ABBV buyout ph 3 PD positive data will put more spot light on sector. Good for $CLNN $SPY $QQQ